Potential marker for preeclampsia. Detection of endogenous HtrA3 proteins in mouse serum.
| Institute |
|---|
| Hudson Institute Of Medical Research |
| SKU: | 154229 |
|---|---|
| Product description: | Potential marker for preeclampsia. Detection of endogenous HtrA3 proteins in mouse serum. HtrA3 are oligomeric serine proteases involved in protein quality control , regulate signal transduction in cell growth, apoptosis, inflammation in cancer, arthritis, neurodegenerative and neuromuscuclar disorders, age-related macular degeneration, pregnancy-specific disease preecampsia |
| Alternate name: | HtrA3 |
| Conjugation: | Unconjugated |
| Molecular weight: | 48 kDa (46.9 kDa plus 1 kDa for the His tag) |
| Immunogen: | HtrA3-L-S305A protein |
| Immunogen Uniprot ID: | P83110, HTRA3_HUMAN |
| Myeloma used: | Sp2/0-Ag14 |
| Cat. #: | 154229 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Tissue-specific biology |
| Application: | IHC ; WB |
| Target: | Mouse HtrA3 (high temperature requirement factor A) |
| Reactivity: | Mouse |
| Host: | Mouse |
| Class: | Monoclonal |
| Target background: | Potential marker for preeclampsia. Detection of endogenous HtrA3 proteins in mouse serum. HtrA3 are oligomeric serine proteases involved in protein quality control , regulate signal transduction in cell growth, apoptosis, inflammation in cancer, arthritis, neurodegenerative and neuromuscuclar disorders, age-related macular degeneration, pregnancy-specific disease preecampsia |
|---|
| Format: | Liquid |
|---|---|
| Shipping conditions: | Dry ice |
| References: |
27932697 HtrA3 as an early marker for preeclampsia: specific monoclonal antibodies and sensitive high-throughput assays for serum screening. Dynon et al. 2012. PLoS One. 7(9):e45956. PMID: 23049902. |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.